Intraocular lymphoma: a series of 14 patients with clinicopathological features and treatment outcomes (Q35152397)

6 August 2017

title

Intraocular lymphoma: a series of 14 patients with clinicopathological features and treatment outcomes (English)

1 reference

6 August 2017

1 reference

Hoffman PM

1

1 reference

6 August 2017

McKelvie P

2

1 reference

6 August 2017

Hall AJ

3

1 reference

6 August 2017

Stawell RJ

4

1 reference

6 August 2017

Santamaria JD

5

1 reference

6 August 2017

publication date

1 May 2003

1 reference

6 August 2017

1 reference

6 August 2017

volume

17

1 reference

6 August 2017

issue

4

1 reference

6 August 2017

page(s)

513-521

1 reference

Primary Central Nervous System Lymphoma

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6700378

Increasing incidence of primary brain lymphoma in the US

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6700378

Nonparametric Estimation from Incomplete Observations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6700378

Clinical features, laboratory investigations, and survival in ocular reticulum cell sarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6700378

Intraocular lymphoma. Clinical and histopathologic diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6700378

The clinical spectrum of ocular lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6700378

Primary intraocular lymphoma (ocular reticulum cell sarcoma) diagnosis and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6700378

Ocular-central nervous system lymphoma mimicking posterior scleritis with exudative retinal detachment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6700378

Intraocular lymphoma presenting as retinal vasculitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6700378

Intraocular lymphoma: immunological and cytological analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6700378

Immunophenotypic characterization of an unusual T-cell lymphoma presenting as anterior uveitis. A clinicopathologic case report

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6700378

Intraocular T-cell lymphoma mimicking a ring melanoma. First manifestation of systemic disease. Report of a case and survey of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6700378

Intraocular involvement with subretinal pigment epithelium infiltrates by mycosis fungoides

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6700378

Ocular involvement in mycosis fungoides

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6700378

Primary T-cell lymphoma of the brainstem

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6700378

Uveitis masquerade syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6700378

Intravitreal methotrexate as an adjunctive treatment of intraocular lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6700378

Intravitreal chemotherapy for the treatment of recurrent intraocular lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6700378

Malignant lymphoma of the uveal tract

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6700378

7 January 2021

Pathology with clinical correlations of primary central nervous system non-Hodgkin's lymphoma. The Massachusetts General Hospital experience 1958-1989

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6700378

7 January 2021

Chemotherapy without radiation therapy as initial treatment for primary CNS lymphoma in older patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6700378

7 January 2021

Phase II trial of chemotherapy alone for primary CNS and intraocular lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6700378

7 January 2021

Ocular and central nervous system lymphoma: clinical features and diagnosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6700378

7 January 2021

Diagnosis of intraocular lymphoma by flow cytometry

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6700378

7 January 2021

Retinal manifestations of ocular lymphoma (reticulum cell sarcoma)

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6700378

7 January 2021

Ocular involvement by a peripheral T-cell lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6700378

7 January 2021

Ocular manifestations of adult T-cell leukemia/lymphoma. A clinicopathologic study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6700378

7 January 2021

T-cell lymphoproliferative disorder of vitreous associated with mycosis fungoides

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6700378

7 January 2021

Immunophenotypic shift in a case of mycosis fungoides with vitreous invasion

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6700378

7 January 2021

Bilateral granulomatous panuveitis as initial presentation of diffuse systemic T cell lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6700378

7 January 2021

Mycosis fungoides. Intraocular and central nervous system involvement

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6700378

7 January 2021

Primary central nervous system T-cell lymphoma. Case report

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6700378

7 January 2021

Primary central nervous system lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6700378

7 January 2021

Primary intraocular lymphoma.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6700378

7 January 2021

Role of intravitreal methotrexate in the management of primary central nervous system lymphoma with ocular involvement

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6700378

7 January 2021

Identifiers

DOI

10.1038/SJ.EYE.6700378

1 reference

6 August 2017

1 reference